No abstract

No abstract

The dynamics of HIV-1 replication in vivo are largely unknown yet they are critical to our understanding of disease pathogenesis. Experimental drugs that are potent inhibitors of viral replication can be used to show that the composite lifespan of plasma virus and virus-producing cells is remarkably short (half-life approximately 2 days). Almost complete replacement of wild-type virus in plasma by drug-resistant variants occurs after fourteen days, indicating that HIV-1 viraemia is sustained primarily by a dynamic process involving continuous rounds of de novo virus infection and replication and rapid cell turnover.

Current HIV-1 vaccines elicit strain-specific neutralizing antibodies. However, cross-reactive neutralizing antibodies arise in ~20% of HIV-1-infected individuals, and details of their generation could provide a roadmap for effective vaccination. Here we report the isolation, evolution and structure of a broadly neutralizing antibody from an African donor followed from time of infection. The mature antibody, CH103, neutralized ~55% of HIV-1 isolates, and its co-crystal structure with gp120 revealed a novel loop-based mechanism of CD4-binding site recognition. Virus and antibody gene sequencing revealed concomitant virus evolution and antibody maturation. Notably, the CH103-lineage unmutated common ancestor avidly bound the transmitted/founder HIV-1 envelope glycoprotein, and evolution of antibody neutralization breadth was preceded by extensive viral diversification in and near the CH103 epitope. These data elucidate the viral and antibody evolution leading to induction of a lineage of HIV-1 broadly neutralizing antibodies and provide insights into strategies to elicit similar antibodies via vaccination.

Most great ape genetic variation remains uncharacterized; however,\ud its study is critical for understanding population history, recombination,\ud selection and susceptibility to disease.Herewe sequence\ud to high coverage a total of 79 wild- and captive-born individuals\ud representing all six great ape species and seven subspecies and report\ud 88.8 million single nucleotide polymorphisms. Our analysis provides\ud support for genetically distinct populations within each species,\ud signals of gene flow, and the split of common chimpanzees\ud into two distinct groups: Nigeria–Cameroon/western and central/\ud eastern populations.We find extensive inbreeding in almost all wild\ud populations, with eastern gorillas being the most extreme. Inferred\ud effective population sizes have varied radically over timein different\ud lineages and this appears to have a profound effect on the genetic\ud diversity at, or close to, genes in almost all species. We discover and\ud assign 1,982 loss-of-function variants throughout the human and\ud great ape lineages, determining that the rate of gene loss has not\ud been different in the human branch compared to other internal\ud branches in the great ape phylogeny. This comprehensive catalogue\ud of great ape genomediversity provides a framework for understanding\ud evolution and a resource for more effective management of wild\ud and captive great ape populations